Type 2 diabetes - Which BGLs matter? - The fasting, pre- and post-prandial glycaemia debate

Australian Family Physician

Volumn 37, Issue 11, 2008, Pages 929-931

  Phillips, Patrick J ^a   Twigg, Stephen M ^b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; POSTPRANDIAL PERIOD;

EID: 58149463793     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. Lancet 1998;352:837-53.
3. Phillips P. 'KISS - keep insulin safe and simple'. Med Today (Suppl) August 2007.
4. Harris P, Mann L, Phillips P, Snowdon T, Webster C. Diabetes management in general practice. 13th edn. Canberra: Diabetes Australia and The RACGP, 2007.